Income Tax Expense (Benefit) of Achilles Therapeutics plc from 31 Dec 2020 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Achilles Therapeutics plc quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2020 to 30 Jun 2024.
  • Achilles Therapeutics plc Income Tax Expense (Benefit) for the quarter ending 30 Jun 2024 was $8,000.
  • Achilles Therapeutics plc annual Income Tax Expense (Benefit) for 2023 was $491,000, a 342% increase from 2022.
  • Achilles Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was $111,000, a 200% increase from 2021.
  • Achilles Therapeutics plc annual Income Tax Expense (Benefit) for 2021 was $37,000, a 1133% increase from 2020.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Achilles Therapeutics plc Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $8,000 +$42,000 01 Apr 2024 30 Jun 2024 6-K 14 Aug 2024 2024 Q2
Q2 2023 $34,000 -$48,000 -343% 01 Apr 2023 30 Jun 2023 6-K 14 Aug 2024 2024 Q2
Q2 2022 $14,000 01 Apr 2022 30 Jun 2022 6-K 04 Aug 2023

Achilles Therapeutics plc Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $491,000 +$380,000 +342% 01 Jan 2023 31 Dec 2023 20-F 04 Apr 2024 2023 FY
2022 $111,000 +$74,000 +200% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2024 2023 FY
2021 $37,000 +$34,000 +1133% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2024 2023 FY
2020 $3,000 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.